Triple Negative Breast Neoplasms

Known as: Triple Negative Breast Neoplasms [Disease/Finding], ER Negative PR Negative HER2 Negative Breast Neoplasms, ER Negative PR Negative HER2 Negative Breast Cancer 
An invasive breast carcinoma which is negative for expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Patients with breast cancer along with metastatic estrogen and progesterone receptor (ER/PR)- and human epidermal growth factor… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 2
Is this relevant?
Review
2016
Review
2016
Cancer has been considered as temporal and spatial aberrations of normal development in tissues. Similarities between mammary… (More)
  • figure 1
  • figure 2
Is this relevant?
Review
2014
Review
2014
Triple-negative breast cancer (TNBC) is a heterogeneous disease; gene expression analyses recently identified six distinct TNBC… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Primary triple-negative breast cancers (TNBCs), a tumour type defined by lack of oestrogen receptor, progesterone receptor and… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Triple-negative breast cancer (TNBC) is a highly diverse group of cancers, and subtyping is necessary to better identify… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Research focused on the analysis and classification of breast tumors, primarily using DNA microarrays and patterns of gene… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2009
Review
2009
Of the estimated 1 million cases of breast cancer diagnosed annually worldwide, it is estimated that over 170,000 will harbor the… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE To compare the clinical features, natural history, and outcomes for women with "triple-negative" breast cancer with women… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2007